CN Patent

CN108024993B — 取代的2-苯胺基嘧啶衍生物及其作为表皮生长因子受体调节剂

Assigned to Beta Pharma Shanghai Co ltd · Expires 2020-11-06 · 6y expired

What this patent protects

本申请中公开了新型取代的2‑苯胺基嘧啶衍生物，及其药学上可接受的盐，溶剂化物，前药，及其组合物，其可用于治疗或预防由表皮生长因子受体(EGFR)介导的疾病或医学病症，包括但不限于多种癌症。

USPTO Abstract

本申请中公开了新型取代的2‑苯胺基嘧啶衍生物，及其药学上可接受的盐，溶剂化物，前药，及其组合物，其可用于治疗或预防由表皮生长因子受体(EGFR)介导的疾病或医学病症，包括但不限于多种癌症。

Drugs covered by this patent

Patent Metadata

Patent number
CN108024993B
Jurisdiction
CN
Classification
—
Expires
2020-11-06
Drug substance claim
No
Drug product claim
No
Assignee
Beta Pharma Shanghai Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.